Sanfilippo syndrome
2023 - 12 - 7
Kyowa Kirin acquires rights to OTL-201 for Sanfilippo syndrome type A (Sanfilippo News)
The Japanese pharmaceutical Kyowa Kirin portfolio will soon include the OTL-201 gene therapy for Sanfilippo syndrome type A, after the company announce the ...
Explore the last week
- 2024 - 12 - 20, 20 topics across 190 articles.
- 2024 - 12 - 19, 44 topics across 558 articles.
- 2024 - 12 - 18, 41 topics across 543 articles.
- 2024 - 12 - 17, 34 topics across 360 articles.
- 2024 - 12 - 16, 44 topics across 494 articles.
- 2024 - 12 - 15, 45 topics across 721 articles.
- 2024 - 12 - 14, 37 topics across 470 articles.